chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Influenza like illness, Pyrexia, SARS-CoV-2 antibody test, SARS-CoV-2 test
Clinical narrative: Tested positive for covid-19; Fever/ 103 temperature; Flu like symptoms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (Tested positive for covid-19), INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Fever/ 103 temperature) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included Blood donation on 31-Jan-2021.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 02-Feb-2021, the patient experienced PYREXIA (Fever/ 103 temperature). On 07-Feb-2021, the patient experienced COVID-19 (Tested positive for covid-19). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for Sleep disorder, at an unspecified dose and frequency. On 04-Feb-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Fever/ 103 temperature) had resolved. At the time of the report, COVID-19 (Tested positive for covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, SARS-CoV-2 antibody test: negative (Negative) No covid antibodies in her system. On 07-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: Follow-up information received on 01-MAR-2021 contains significant information: Added medical history (blood donation), lab data (COVID antibody test), start date of all events. The outcome of the events (Fever and Flu symptoms) changed from unknown to recovered.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness
Clinical narrative: Decrease in his energy levels; Feeling dizzy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Decrease in his energy levels) and DIZZINESS (Feeling dizzy) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ASTHENIA (Decrease in his energy levels) and DIZZINESS (Feeling dizzy). On 16-Feb-2021, ASTHENIA (Decrease in his energy levels) and DIZZINESS (Feeling dizzy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Sex: F
Vaccine: COVID19
Symptoms: Eosinophil count increased, Pruritus, Urticaria
Clinical narrative: hives on their arm, that lasted 2 days.; it was itchy and annoying; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on their arm, that lasted 2 days.) and PRURITUS (it was itchy and annoying) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa drug) and Penicillin allergy. Concomitant products included ACYCLOVIR [ACICLOVIR] for Herpes infection, LEVOTHYROXINE for Thyroid disorder.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced URTICARIA (hives on their arm, that lasted 2 days.) and PRURITUS (it was itchy and annoying). The patient was treated with HYDROCORTISONE for Hives, at an unspecified dose and frequency. On 12-Feb-2021, URTICARIA (hives on their arm, that lasted 2 days.) had resolved. At the time of the report, PRURITUS (it was itchy and annoying) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Eosinophil count increased (0-6): 10,6 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced URTICARIA (Hives). The patient was treated with HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) (topical) ongoing since an unknown date at a dose of 1 dosage form. On 12-Feb-2021, URTICARIA (Hives) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported her hand, forearm, left shoulder, and outer thigh were red and itchy.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up received on 14-JUL-2021 and included event outcome.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Influenza like illness, Myalgia
Clinical narrative: Flu like symptoms; Weakness; Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (Weakness), MYALGIA (Muscle pain) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (Weakness), MYALGIA (Muscle pain) and HEADACHE (Headache). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (Weakness), MYALGIA (Muscle pain) and HEADACHE (Headache) outcome was unknown.            No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Hypoaesthesia, Paraesthesia, Sinus disorder
Clinical narrative: Hypoaesthesia; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of HYPOAESTHESIA (Hypoaesthesia), SINUS DISORDER (Sinus disorder), the second episode of HYPOAESTHESIA (Hypoaesthesia) and PARAESTHESIA (tingling in fingers) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.  Concurrent medical conditions included High cholesterol. Concomitant products included ATORVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), MULTI VITAMINS & MINERALS and IRON for an unknown indication.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced the first episode of HYPOAESTHESIA (Hypoaesthesia). On 26-Feb-2021, the patient experienced SINUS DISORDER (Sinus disorder) and the second episode of HYPOAESTHESIA (Hypoaesthesia). On an unknown date, the patient experienced PARAESTHESIA (tingling in fingers). At the time of the report, SINUS DISORDER (Sinus disorder), the last episode of HYPOAESTHESIA (Hypoaesthesia) and PARAESTHESIA (tingling in fingers) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) Normal.         Treatment was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Mar-2021: Follow up received on 02-mar-2021, Event start dates and 1 dose information updated.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Vaccination site reaction; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Vaccination site reaction) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Vaccination site reaction). At the time of the report, VACCINATION SITE REACTION (Vaccination site reaction) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-040453, MOD21-040270 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD21-040453:same reporter MOD21-040270:same reporter
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Coronavirus test
Clinical narrative: Tested positive for COVID-19 after 1st dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19 after 1st dose of the vaccine) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19 after 1st dose of the vaccine). At the time of the report, COVID-19 (Tested positive for COVID-19 after 1st dose of the vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Coronavirus test: (Positive) Tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Itchy rash; Red rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash) and RASH ERYTHEMATOUS (Red rash) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Cholesterol blood excessive and Allergy NOS. Concomitant products included LORATADINE (ALLERCLEAR) for Allergy, WARFARIN for Anticoagulant therapy, EZETIMIBE, SIMVASTATIN (VYTORIN) for Cholesterol blood excessive, FUROSEMIDE for Diuretic therapy, LOSARTAN for Hypertension, VITAMIN D3 for Loss of energy, POTASSIUM CHLORIDE for Potassium replacement, CINNAMON [CINNAMOMUM VERUM] for an unknown indication.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced RASH PRURITIC (Itchy rash) and RASH ERYTHEMATOUS (Red rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Itchy rash) and RASH ERYTHEMATOUS (Red rash) outcome was unknown.            Patient stated that she developed rash as big as her palm that was red and itchy.   Action taken with mRNA-1273 in response to events was not applicable.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on right side at waist and upper thigh; This spontaneous case was reported by a consumer and describes the occurrence of   in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Chills, Cognitive disorder, Fatigue, Glossodynia
Clinical narrative: allergic reaction; arm had a teeny tiny sore; lip was swollen; very sore tongue; Tongue was swollen; body aches; chills; became very tired; severe headache; cognitive fogginess; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (allergic reaction), COGNITIVE DISORDER (cognitive fogginess), GLOSSODYNIA (very sore tongue), SWOLLEN TONGUE (Tongue was swollen) and PAIN IN EXTREMITY (arm had a teeny tiny sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced COGNITIVE DISORDER (cognitive fogginess). On 17-Feb-2021, the patient experienced HEADACHE (severe headache). On 18-Feb-2021, the patient experienced MYALGIA (body aches), CHILLS (chills) and FATIGUE (became very tired). On 19-Feb-2021, the patient experienced GLOSSODYNIA (very sore tongue), SWOLLEN TONGUE (Tongue was swollen) and LIP SWELLING (lip was swollen). On an unknown date, the patient experienced ALLERGY TO VACCINE (allergic reaction) and PAIN IN EXTREMITY (arm had a teeny tiny sore). On 16-Feb-2021, COGNITIVE DISORDER (cognitive fogginess) had resolved. At the time of the report, ALLERGY TO VACCINE (allergic reaction), GLOSSODYNIA (very sore tongue), SWOLLEN TONGUE (Tongue was swollen), PAIN IN EXTREMITY (arm had a teeny tiny sore), LIP SWELLING (lip was swollen), MYALGIA (body aches), CHILLS (chills), FATIGUE (became very tired) and HEADACHE (severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She had an allergic reaction. She did not go to the hospital and did not receive treatment for her symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: No specific follow-up information recorded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lip swelling, Myalgia, Pain in extremity, Swollen tongue
Clinical narrative: allergic reaction; arm had a teeny tiny sore; lip was swollen; very sore tongue; Tongue was swollen; body aches; chills; became very tired; severe headache; cognitive fogginess; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (allergic reaction), COGNITIVE DISORDER (cognitive fogginess), GLOSSODYNIA (very sore tongue), SWOLLEN TONGUE (Tongue was swollen) and PAIN IN EXTREMITY (arm had a teeny tiny sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced COGNITIVE DISORDER (cognitive fogginess). On 17-Feb-2021, the patient experienced HEADACHE (severe headache). On 18-Feb-2021, the patient experienced MYALGIA (body aches), CHILLS (chills) and FATIGUE (became very tired). On 19-Feb-2021, the patient experienced GLOSSODYNIA (very sore tongue), SWOLLEN TONGUE (Tongue was swollen) and LIP SWELLING (lip was swollen). On an unknown date, the patient experienced ALLERGY TO VACCINE (allergic reaction) and PAIN IN EXTREMITY (arm had a teeny tiny sore). On 16-Feb-2021, COGNITIVE DISORDER (cognitive fogginess) had resolved. At the time of the report, ALLERGY TO VACCINE (allergic reaction), GLOSSODYNIA (very sore tongue), SWOLLEN TONGUE (Tongue was swollen), PAIN IN EXTREMITY (arm had a teeny tiny sore), LIP SWELLING (lip was swollen), MYALGIA (body aches), CHILLS (chills), FATIGUE (became very tired) and HEADACHE (severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She had an allergic reaction. She did not go to the hospital and did not receive treatment for her symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash
Clinical narrative: breaking out into a hot rash all over her body including chest and face; hands are swelling and feel splotchy; hands are swelling and feel splotchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH (breaking out into a hot rash all over her body including chest and face), PERIPHERAL SWELLING (hands are swelling and feel splotchy) and RASH (hands are swelling and feel splotchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced RASH (breaking out into a hot rash all over her body including chest and face), PERIPHERAL SWELLING (hands are swelling and feel splotchy) and RASH (hands are swelling and feel splotchy). At the time of the report, RASH (breaking out into a hot rash all over her body including chest and face), PERIPHERAL SWELLING (hands are swelling and feel splotchy) and RASH (hands are swelling and feel splotchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Confusional state, Feeling abnormal, Memory impairment, Vaccination complication
Clinical narrative: Confusion; Fogginess; Forgetfulness that is not typical to the patient; Transiet cognitive side effects with no fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of CONFUSIONAL STATE (Confusion), FEELING ABNORMAL (Fogginess), MEMORY IMPAIRMENT (Forgetfulness that is not typical to the patient) and VACCINATION COMPLICATION (Transiet cognitive side effects with no fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced CONFUSIONAL STATE (Confusion), FEELING ABNORMAL (Fogginess), MEMORY IMPAIRMENT (Forgetfulness that is not typical to the patient) and VACCINATION COMPLICATION (Transiet cognitive side effects with no fever). At the time of the report, CONFUSIONAL STATE (Confusion), FEELING ABNORMAL (Fogginess), MEMORY IMPAIRMENT (Forgetfulness that is not typical to the patient) and VACCINATION COMPLICATION (Transiet cognitive side effects with no fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment for the event was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: chills; headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of CHILLS (chills) and HEADACHE (headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Adverse event, at a dose of UNK dosage form. At the time of the report, CHILLS (chills) and HEADACHE (headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-028190 (Patient Link).
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site pain
Clinical narrative: Flu like symptoms; A little pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (A little pain at the injection site) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (A little pain at the injection site). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (A little pain at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment drugs were not specified.
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, COVID-19, Cough, Fatigue, Influenza
Clinical narrative: COVID-19 positive; Influenza B positive; dry cough; congestion; tiredness; "major" cold symptoms; bedridden; warmth at injection site; tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warmth at injection site), NASOPHARYNGITIS ("major" cold symptoms), COVID-19 (COVID-19 positive), INFLUENZA (Influenza B positive) and COUGH (dry cough) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ADALIMUMAB (HUMIRA) and METHOTREXATE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INJECTION SITE WARMTH (warmth at injection site) and INJECTION SITE PAIN (tenderness at injection site). On 20-Feb-2021, the patient experienced NASOPHARYNGITIS ("major" cold symptoms) and BEDRIDDEN (bedridden). On 22-Feb-2021, the patient experienced COVID-19 (COVID-19 positive), INFLUENZA (Influenza B positive), COUGH (dry cough), NASAL CONGESTION (congestion) and FATIGUE (tiredness). The patient was treated with OSELTAMIVIR PHOSPHATE (TAMIFLU) for Adverse event, at a dose of UNK dosage form. On 22-Feb-2021, BEDRIDDEN (bedridden) had resolved. At the time of the report, INJECTION SITE WARMTH (warmth at injection site), NASOPHARYNGITIS ("major" cold symptoms), COVID-19 (COVID-19 positive), INFLUENZA (Influenza B positive), COUGH (dry cough), NASAL CONGESTION (congestion), FATIGUE (tiredness) and INJECTION SITE PAIN (tenderness at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Feb-2021, COVID-19: Positive. On 22-Feb-2021, Influenza B virus test: Positive. On 22-Feb-2021, Oxygen saturation: 96-97 percent normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Influenza B virus test, Injection site pain, Injection site warmth, Nasal congestion, Nasopharyngitis
Clinical narrative: COVID-19 positive; Influenza B positive; dry cough; congestion; tiredness; "major" cold symptoms; bedridden; warmth at injection site; tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warmth at injection site), NASOPHARYNGITIS ("major" cold symptoms), COVID-19 (COVID-19 positive), INFLUENZA (Influenza B positive) and COUGH (dry cough) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ADALIMUMAB (HUMIRA) and METHOTREXATE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INJECTION SITE WARMTH (warmth at injection site) and INJECTION SITE PAIN (tenderness at injection site). On 20-Feb-2021, the patient experienced NASOPHARYNGITIS ("major" cold symptoms) and BEDRIDDEN (bedridden). On 22-Feb-2021, the patient experienced COVID-19 (COVID-19 positive), INFLUENZA (Influenza B positive), COUGH (dry cough), NASAL CONGESTION (congestion) and FATIGUE (tiredness). The patient was treated with OSELTAMIVIR PHOSPHATE (TAMIFLU) for Adverse event, at a dose of UNK dosage form. On 22-Feb-2021, BEDRIDDEN (bedridden) had resolved. At the time of the report, INJECTION SITE WARMTH (warmth at injection site), NASOPHARYNGITIS ("major" cold symptoms), COVID-19 (COVID-19 positive), INFLUENZA (Influenza B positive), COUGH (dry cough), NASAL CONGESTION (congestion), FATIGUE (tiredness) and INJECTION SITE PAIN (tenderness at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Feb-2021, COVID-19: Positive. On 22-Feb-2021, Influenza B virus test: Positive. On 22-Feb-2021, Oxygen saturation: 96-97 percent normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation
Clinical narrative: COVID-19 positive; Influenza B positive; dry cough; congestion; tiredness; "major" cold symptoms; bedridden; warmth at injection site; tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warmth at injection site), NASOPHARYNGITIS ("major" cold symptoms), COVID-19 (COVID-19 positive), INFLUENZA (Influenza B positive) and COUGH (dry cough) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ADALIMUMAB (HUMIRA) and METHOTREXATE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INJECTION SITE WARMTH (warmth at injection site) and INJECTION SITE PAIN (tenderness at injection site). On 20-Feb-2021, the patient experienced NASOPHARYNGITIS ("major" cold symptoms) and BEDRIDDEN (bedridden). On 22-Feb-2021, the patient experienced COVID-19 (COVID-19 positive), INFLUENZA (Influenza B positive), COUGH (dry cough), NASAL CONGESTION (congestion) and FATIGUE (tiredness). The patient was treated with OSELTAMIVIR PHOSPHATE (TAMIFLU) for Adverse event, at a dose of UNK dosage form. On 22-Feb-2021, BEDRIDDEN (bedridden) had resolved. At the time of the report, INJECTION SITE WARMTH (warmth at injection site), NASOPHARYNGITIS ("major" cold symptoms), COVID-19 (COVID-19 positive), INFLUENZA (Influenza B positive), COUGH (dry cough), NASAL CONGESTION (congestion), FATIGUE (tiredness) and INJECTION SITE PAIN (tenderness at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Feb-2021, COVID-19: Positive. On 22-Feb-2021, Influenza B virus test: Positive. On 22-Feb-2021, Oxygen saturation: 96-97 percent normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Headache, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; couldn't eat anything; Very bad headaches; 102 °F fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FEEDING DISORDER (couldn't eat anything), HEADACHE (Very bad headaches) and PYREXIA (102 °F fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), FEEDING DISORDER (couldn't eat anything), HEADACHE (Very bad headaches) and PYREXIA (102 °F fever). At the time of the report, PAIN IN EXTREMITY (Sore arm), FEEDING DISORDER (couldn't eat anything), HEADACHE (Very bad headaches) and PYREXIA (102 °F fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided by the reporter.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Pain, Pain in extremity
Clinical narrative: sore shot arms; achy; tired; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (sore shot arms), PAIN (achy) and FATIGUE (tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced DIARRHOEA (Diarrhea). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore shot arms), PAIN (achy) and FATIGUE (tired). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) for Diarrhea, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea) had resolved and PAIN IN EXTREMITY (sore shot arms), PAIN (achy) and FATIGUE (tired) outcome was unknown.            No concomitant medication was reported.    This case was linked to MOD-2021-028613 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: It looked warm; It looked pink; the site of injection was swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (It looked warm), VACCINATION SITE ERYTHEMA (It looked pink) and VACCINATION SITE SWELLING (the site of injection was swelling) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (It looked warm), VACCINATION SITE ERYTHEMA (It looked pink) and VACCINATION SITE SWELLING (the site of injection was swelling). At the time of the report, VACCINATION SITE WARMTH (It looked warm), VACCINATION SITE ERYTHEMA (It looked pink) and VACCINATION SITE SWELLING (the site of injection was swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: Additional information received. Event information updated.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Pollakiuria
Clinical narrative: Abdominal cramps; Frequent urination; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Abdominal cramps), POLLAKIURIA (Frequent urination) and DIARRHOEA (Diarrhea) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced ABDOMINAL PAIN (Abdominal cramps), POLLAKIURIA (Frequent urination) and DIARRHOEA (Diarrhea). The patient was treated with SIMETICONE (GAS-X) at a dose of 1 dosage form. At the time of the report, ABDOMINAL PAIN (Abdominal cramps), POLLAKIURIA (Frequent urination) and DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication were reported
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pyrexia, Swelling
Clinical narrative: Neck swelling; sore arm; Headache; fever; A spontaneous report was received from a consumer concerning a 58-year-old,female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced headache,fever,sore arm and neck swelling.  The patient's medical history, was not reported. Concomitant medications was not reported.  On 22 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 007M20A) intramuscularly for prophylaxis of COVID-19 infection.   On 22 Feb2021, the patient felt headache,fever and sore arm.On 24 Feb21, she had swollen of her gland on the right side of her neck.   No laboratory details was provided.  Treatment information - Dr advice to take Ibuprofen.  Action taken with mRNA-1273 in response to the events was not reported.   At the time of the report,the outcome of the events,headache,fever,sore arm and neck swelling , were considered unknown
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash
Clinical narrative: Itchiness; Rash on upper torso; Soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in the arm), PRURITUS (Itchiness) and RASH (Rash on upper torso) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Allergies which causes itchiness.).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness in the arm). On 06-Feb-2021, the patient experienced PRURITUS (Itchiness) and RASH (Rash on upper torso). On 05-Feb-2021, PAIN IN EXTREMITY (Soreness in the arm) outcome was unknown. At the time of the report, PRURITUS (Itchiness) and RASH (Rash on upper torso) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant and  treatment medications were provided.    This case was linked to MOD21-039854 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Non Significant : email address provided; Sender's Comments:  MOD21-039854:
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling, Lethargy, Limb discomfort, Nausea
Clinical narrative: Nausea; Pain at injection site; Swelling at injection site; Fluid build up under the injection site; Fever; lethargic; Unable to bare weight on leg; hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), INJECTION SITE PAIN (Pain at injection site), INJECTION SITE SWELLING (Swelling at injection site), VACCINATION SITE EXTRAVASATION (Fluid build up under the injection site) and PYREXIA (Fever) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), INJECTION SITE PAIN (Pain at injection site), INJECTION SITE SWELLING (Swelling at injection site), VACCINATION SITE EXTRAVASATION (Fluid build up under the injection site), PYREXIA (Fever), LETHARGY (lethargic), LIMB DISCOMFORT (Unable to bare weight on leg) and VACCINATION SITE WARMTH (hot to touch). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 1 dosage form and PREDNISONE at a dose of 1 dosage form. At the time of the report, NAUSEA (Nausea), INJECTION SITE PAIN (Pain at injection site), INJECTION SITE SWELLING (Swelling at injection site), VACCINATION SITE EXTRAVASATION (Fluid build up under the injection site), PYREXIA (Fever), LETHARGY (lethargic), LIMB DISCOMFORT (Unable to bare weight on leg) and VACCINATION SITE WARMTH (hot to touch) had resolved.            Concomitant medications were not provided by reporter.   This case was linked to MOD-2021-028332 (Patient Link).
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site extravasation, Vaccination site warmth
Clinical narrative: Nausea; Pain at injection site; Swelling at injection site; Fluid build up under the injection site; Fever; lethargic; Unable to bare weight on leg; hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), INJECTION SITE PAIN (Pain at injection site), INJECTION SITE SWELLING (Swelling at injection site), VACCINATION SITE EXTRAVASATION (Fluid build up under the injection site) and PYREXIA (Fever) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), INJECTION SITE PAIN (Pain at injection site), INJECTION SITE SWELLING (Swelling at injection site), VACCINATION SITE EXTRAVASATION (Fluid build up under the injection site), PYREXIA (Fever), LETHARGY (lethargic), LIMB DISCOMFORT (Unable to bare weight on leg) and VACCINATION SITE WARMTH (hot to touch). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 1 dosage form and PREDNISONE at a dose of 1 dosage form. At the time of the report, NAUSEA (Nausea), INJECTION SITE PAIN (Pain at injection site), INJECTION SITE SWELLING (Swelling at injection site), VACCINATION SITE EXTRAVASATION (Fluid build up under the injection site), PYREXIA (Fever), LETHARGY (lethargic), LIMB DISCOMFORT (Unable to bare weight on leg) and VACCINATION SITE WARMTH (hot to touch) had resolved.            Concomitant medications were not provided by reporter.   This case was linked to MOD-2021-028332 (Patient Link).
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort
Clinical narrative: upset stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (upset stomach) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (upset stomach). At the time of the report, ABDOMINAL DISCOMFORT (upset stomach) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: TCR received on 16-07-2021 contain adverse event.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event on 26-Feb-2021.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: very red face, dark red; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (very red face, dark red) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (very red face, dark red). At the time of the report, ERYTHEMA (very red face, dark red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Rash
Clinical narrative: COVID arm reaction; Bullseye rash; m circular rash that does not bother he; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID arm reaction), RASH (Bullseye rash) and RASH (m circular rash that does not bother he) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID arm reaction), RASH (Bullseye rash) and RASH (m circular rash that does not bother he). At the time of the report, COVID-19 (COVID arm reaction), RASH (Bullseye rash) and RASH (m circular rash that does not bother he) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Body aches; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced MYALGIA (Body aches) and HEADACHE (Headache). At the time of the report, MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Insomnia, Pain
Clinical narrative: pain; Can't sleep; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain) and INSOMNIA (Can't sleep) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Nerve compression (Had nerve blocks).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (pain) and INSOMNIA (Can't sleep). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN (pain) and INSOMNIA (Can't sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants was not reported. They're having other physical issues (an unpinched nerves; has nerve blocks) that requires that they got steroids, they've been avoiding it but they're in pain and wants to know if can take them. Tylenol was not working, So they'd get at this point some nerve block or steroid.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: UPDATED CONTACT INFORMATION On 09-Aug-2021: Non significant follow up